When is the Right Time for Prostate Surgery? Key Considerations and Surgical Criteria in Seongjeong-dong
Why Do Men Delay Prostate Surgery and What Are the Risks of Waiting Too Long?
Benign prostatic hyperplasia (BPH) is a progressive disease characterized by the non-malignant proliferation of the prostatic transition zone tissue, which anatomically compresses the prostatic urethra and leads to lower urinary tract symptoms (LUTS). Many patients enduring these symptoms hesitate to pursue surgical treatment due to fears of post-operative complications or extended recovery times. However, maintaining conservative management for too long can result in severe, irreversible deterioration of detrusor muscle function within the bladder wall.
According to multiple observational studies and meta-analyses, patients who delay necessary surgical intervention show a significantly higher rate of post-void residual urine accumulation, which eventually compromises renal function. When the bladder outlet obstruction remains untreated, the pressure required to void increases, causing bladder trabeculation and a gradual loss of compliance. Over time, this makes complete recovery of normal voiding habits difficult, even after successful surgical decompression.
Treatment timing: Surgical intervention is typically indicated when the International Prostate Symptom Score (IPSS) remains consistently in the severe range (20–35) despite medical therapy, or when objective bladder outlet obstruction is documented.
Non-surgical care: Conservative management—including lifestyle modifications, alpha-blockers, and 5-alpha reductase inhibitors (5-ARIs)—is highly reasonable for mild symptoms (IPSS under 8) and moderate symptoms without anatomical complications.
Treatment selection: The choice of surgical procedure depends heavily on prostate gland volume, individual risk factors, the presence of a median lobe, and patient preferences regarding the preservation of sexual and ejaculatory functions.
How Do Different Prostate Procedures Compare in Safety and Efficacy?
Modern urological advancements offer several surgical modalities designed to relieve obstruction while minimizing complications. Historically, transurethral resection of the prostate (TURP) served as the definitive standard. Today, newer technologies like Holmium Laser Enucleation of the Prostate (HoLEP) and minimally invasive therapies like Prostatic Urethral Lift (PUL) provide targeted alternatives tailored to specific gland sizes and patient health profiles.
According to domestic and international clinical guidelines, laser-based enucleation techniques demonstrate superior efficacy in removing hyperplastic tissue with a lower risk of post-operative bleeding, making them ideal for larger prostate glands. However, outcomes may differ in exceptional cases such as patients with severe pre-existing neurogenic bladder dysfunction or pelvic radiation history, where recovery of normal voiding may be compromised regardless of the surgical method used.
| Procedure Type | Primary Advantage | Primary Limitation | Est. Hospital Stay |
|---|---|---|---|
| TURP (Transurethral Resection) | Extensive long-term clinical track record and high durability. | Higher risk of bleeding and transient transurethral resection syndrome. | 2 to 4 Days |
| HoLEP (Laser Enucleation) | Extremely low recurrence; suitable for large glands (>80ml). | Requires high technical expertise and a steep specialist learning curve. | 1 to 2 Days |
| PUL (Urolift Implant) | Preserves sexual function and retrograde ejaculation is avoided. | Less effective for very large prostates or obstructive median lobes. | Same Day / Outpatient |
According to official guidelines from the European Association of Urology (EAU) in 2023, both quantitative anatomical criteria—such as prostate gland volume measured via transrectal ultrasound—and clinical patient symptoms must be evaluated holistically before electing surgical interventions.
What is the Essential Clinical Checklist Before Proceeding with Surgery?
For patients in the Seongjeong-dong region seeking expert urological assessment, certain diagnostic indicators must be systematically checked. A comprehensive evaluation prevents premature surgical choices and ensures that the optimal physiological outcome is achieved.
- IPSS Score Assessment: Determining if symptoms are moderate (8-19) or severe (20-35).
- Uroflowmetry & Post-Void Residual (PVR): Objective measurement of urine flow rate (usually <10 ml/s indicates obstruction) and residual urine.
- Prostate-Specific Antigen (PSA) Test: Routine screening to rule out prostate malignancy prior to tissue resection.
- Transrectal Ultrasound (TRUS): Accurately mapping the prostate volume and identifying any middle lobe hyperplasia.
- Cystoscopy: Optional visual inspection of the urethral pathway and bladder wall for trabeculation.
Decision-Making Flowchart:
Step 1 (IF): If medication fails to improve lower urinary tract symptoms, or if IPSS remains above 20.
Step 2 (THEN): Then measure the precise gland volume and check for the presence of an obstructive median lobe.
Step 3 (DECISION): If volume is >80ml with no severe surgical contraindications, recommend laser enucleation (HoLEP); if <80ml and preserving sexual function is the highest priority, evaluate suitability for a prostatic urethral lift.
Frequently Asked Questions FAQ
QDoes prostate surgery cause sexual dysfunction or retrograde ejaculation?
While modern minimally invasive techniques like the prostatic urethral lift have a near-zero percent risk of sexual dysfunction, traditional procedures like TURP and HoLEP carry a 65% to 80% chance of retrograde ejaculation due to the relaxation of the bladder neck. However, these procedures rarely affect erectile function or the physical sensation of climax when performed by experienced specialists.
QWhat is the typical recovery timeline after receiving care at a Seongjeong-dong urology clinic?
Most patients who undergo advanced laser prostatectomy can expect the urinary catheter to be removed within 1 to 2 days. Complete internal mucosal healing typically takes about 4 to 6 weeks, during which heavy lifting, strenuous exercise, and sexual activity should be strictly avoided to prevent secondary bleeding.
QHow high is the long-term recurrence rate of benign prostatic hyperplasia?
Complete resection techniques like HoLEP have an extremely low long-term recurrence rate, estimated at less than 1% to 2% over a 10-year period. Since the hyperplastic transitional tissue is entirely enucleated down to the surgical capsule, the chances of tissue regrowth causing subsequent urinary blockage are minimal.
This content is general medical information, and individual treatment decisions should be made through imaging tests and in-person medical evaluation.
Author: Medical content editor based on medical information research
Reviewed by: Specialist consultation from the relevant department
Last reviewed: 2026-08-05
Reference guideline: American Urological Association (AUA) 2023 Guidelines on the Management of Benign Prostatic Hyperplasia
Medical neutrality and closing note
The core of medical decision-making is not to follow a specific device or a trending procedure, but to choose an option that fits each patient’s individual anatomy, condition, risk level, and treatment goals. Every procedure has both advantages and limitations, so decisions should be made after sufficient discussion with an experienced specialist.
[Medical information and copyright notice]
This content is a professional medical column prepared based on medical consultation from 굿모닝비뇨기과.
The infographics used in this article are created to support understanding and may differ from actual clinical results.
The information provided is a general medical guideline, and accurate diagnosis and treatment require an in-person evaluation by a qualified specialist.